Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

[thumbnail of Publisher's version]
Preview
PDF (Publisher's version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
386kB

Item Type:Letter
Title:Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
Creators Name:Immisch, L., Papafotiou, G., Popp, O., Mertins, P., Blankenstein, T. and Willimsky, G.
Keywords:Glioma, HLA-A2 Antigen, Histones, Immunotherapy, Mutation
Source:Journal for ImmunoTherapy of Cancer
ISSN:2051-1426
Publisher:BMJ Publishing Group
Volume:11
Number:3
Page Range:e006784
Date:14 March 2023
Official Publication:https://doi.org/10.1136/jitc-2023-006784
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library